Riccardo Bomben

22PUBLICATIONS
163CO-AUTHORS
Haematological tumoursMolecular targetsImmunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 08, 2026
Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial.

|Mar 28, 2026
Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. Cancers 2022, 14, 1630.

Federica Tonon, Maja Cemazar, Urska Kamensek

|Jun 18, 2025
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia.

Filippo Vit, Tamara Bittolo, Antonella Zucchetto

|May 22, 2025
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.

Gabriele Varano, Silvia Lonardi, Paola Sindaco

|Jan 18, 2025
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Riccardo Moia, Donatella Talotta, Lodovico Terzi Di Bergamo

|Dec 17, 2024
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Jana Nabki, Bashar Al Deeban, Abel Mehari Sium

Pageof 4

Frequent Collaborators

9 joint publications

Valter Gattei

5 joint publications

Riccardo Moia

4 joint publications

Giovanni D'Arena

4 joint publications

Francesca Maria Rossi